Clinical Trials Browser

Withdrawn × INDUSTRY × Locally Advanced Breast Cancer (LABC) × Clear all

NCT07150767 2025-12-02

A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer

Phase 1 Withdrawn

Locally Advanced Breast Cancer (LABC)